SCHEMBL4555722

SCHEMBL4555722

CCCc1ccc(S(=O)(=O)N2CCCCCC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.67
L3MBTL1 Q9Y468 2/20 0.61
TSHR P16473 2/20 0.61
MAPK1 P28482 1/20 0.61
RECQL P46063 1/20 0.61
GAA P10253 2/20 0.60
NPSR1 Q6W5P4 1/20 0.60
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
HTT P42858 1/20 0.57
LMNA P02545 1/20 0.57
KCNH2 Q12809 2/20 0.56
HRH3 Q9Y5N1 2/20 0.56
MAPT P10636 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
TDP1 Q9NUW8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15010487 0.98 USP2 (0.63) USP2L3MBTL1TSHRMAPK1RECQL
SCHEMBL7861726 0.88 L3MBTL1 (0.63) USP2L3MBTL1TSHRMAPK1RECQL
SCHEMBL12189227 0.86 USP2 (0.71) USP2L3MBTL1TSHRMAPK1RECQL
SCHEMBL12646347 0.84 USP2 (0.68) USP2L3MBTL1TSHRMAPK1RECQL
SCHEMBL13176134 0.84 LMNA (0.68) USP2L3MBTL1TSHRGAAMEN1
SCHEMBL17069869 0.84 USP2 (0.62) USP2L3MBTL1TSHRGAANPSR1
SCHEMBL7077124 0.84 MAPT (0.59) USP2GAALMNAMAPTSMN1; SMN2
SCHEMBL27532497 0.83 USP2 (0.67) USP2GAANPSR1MEN1KMT2A
SCHEMBL10312340 0.83 USP2 (0.61) USP2L3MBTL1TSHRMAPK1RECQL
SCHEMBL27538663 0.81 GPR183 (0.53) USP2L3MBTL1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 EP disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 WO disclosed